Ipilimumab/nivolumab/pembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69043-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[31] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 331 - 331
[32] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 356 - 356
[33] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 546 - 546
[34] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2046 (1) : 340 - 340
[35] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2041 (1) : 330 - 330
[36] Cisplatin/nivolumab/pembrolizumabLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1938 (1) : 407 - 407
[37] Atezolizumab/Nivolumab/PembrolizumabLack of efficacy : 36 case reports
Reactions Weekly, 2024, 2017 (1) : 83 - 83
[38] Ipilimumab/nivolumab/prednisoneHaemophagocytic lymphohistiocytosis and lack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 266 - 266
[39] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1900 (1) : 274 - 274
[40] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 366 - 366

← 1 2 3 4 5 →